EZH2 and cancer: For example, EPZ-6438 (an EZH2 inhibitor that represses PRC2 activity) inhibits the proliferation of cancer cells in haematological malignancies [51,131,132] and induces apoptosis by restoring the expression of pro-apoptotic factors (such as FBXO32) [133].